Post-Polycythemia Vera Myelofibrosis (PPV-MF) Pipeline Review, H2 2012 New Report
Post-polycythemia vera myelofibrosis (PPV-MF) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Post-polycythemia vera myelofibrosis (PPV-MF), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Post-polycythemia vera myelofibrosis (PPV-MF).
View full press release